Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 6, 2019
- Accepted for publication December 4, 2019
- Published online August 3, 2020.
Article Versions
- previous version (March 13, 2020 - 14:12).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Caroline Rousseau1,2,
- David M. Goldenberg3,4,
- Mathilde Colombié1,
- Jean-Charles Sébille1,
- Philippe Meingan5,
- Ludovic Ferrer2,6,
- Pierre Baumgartner7,
- Evelyne Cerato8,
- Damien Masson9,
- Mario Campone10,
- Aurore Rauscher7,
- Vincent Fleury1,
- Catherine Labbe5,
- Alain Faivre Chauvet11,
- Jean-Sebastien Fresnel10,
- Claire Toquet12,
- Jacques Barbet13,
- Robert M. Sharkey3,
- Loic Campion2,14 and
- Françoise Kraeber-Bodéré1,2,11
- 1Nuclear Medicine, ICO Cancer Center, Nantes, France
- 2CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France
- 3Immunomedics, Inc., Morris Plains, New Jersey
- 4IBC Pharmaceuticals, Inc., Morris Plains, New Jersey
- 5Radiology, ICO Cancer Center, Nantes, France
- 6Physics, ICO Cancer Center, Nantes, France
- 7Pharmacy, ICO Cancer Center, Nantes, France
- 8DRCI, University Hospital, Nantes, France
- 9Biology Department, University Hospital, Nantes, France
- 10Oncology, ICO Cancer Center, Nantes, France
- 11Nuclear Medicine, University Hospital, Nantes, France
- 12Pathology Department, University Hospital, Nantes, France
- 13GIP Arronax, Saint-Herblain, France; and
- 14Biometrics, ICO Cancer Center, Nantes, France
- For correspondence or reprints contact: Caroline Rousseau, ICO Gauducheau Cancer Center, Boulevard Monod, 44805 Saint Herblain Cedex, France. E-mail: c-rousseau{at}ico.unicancer.fr